Results 281 to 290 of about 195,645 (350)

Cyclosporin A Followed by the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis with Corticosteroid

, 2003
Naohiko Inase, Megumi Sawada, Yoshio Ohtani, Shuji MlYAKE, Susumu Isogai, Hiroyuki Sakashita, Yasunari Miyazaki, Yasuyuki Yoshizawa   +7 more
openalex   +1 more source

Safety and Tolerability of Human Monoclonal Antibody FG-3019, Anti-Connective Tissue Growth Factor, in Patients with Idiopathic Pulmonary Fibrosis [PDF]

, 2004
Yolanda Mageto, KR Flaherty, K. Brown, Abigail Fong, Ganesh Raghu   +4 more
openalex   +1 more source

Distinct cAMP Regulation in Scleroderma Lung and Skin Myofibroblasts Governs Their Dedifferentiation via p38α Inhibition

The FASEB Journal, Volume 39, Issue 12, 30 June 2025.
The second messenger cyclic AMP (cAMP) dedifferentiates pathologic lung and skin myofibroblasts derived from patients with scleroderma by inhibiting the MAPK p38α. Though cAMP has anti‐fibrotic effects in fibroblasts from both organs, the cellular capacity to generate cAMP in response to the canonical stimulus prostaglandin E2 (PGE2) is substantially ...
Jared D. Baas, John Varga, Carol Feghali‐Bostwick, Marc Peters‐Golden, Sean M. Fortier   +4 more
wiley   +1 more source

Predictive models and WTAP targeting for idiopathic pulmonary fibrosis (IPF). [PDF]

Sci Rep
Li GD, Li J, Fan JQ, Li JY, Zhao B, Chen X.   +5 more
europepmc   +1 more source

A Clinical Study of Idiopathic Pulmonary Fibrosis Based on Autopsy Studies in Elderly Patients

, 2003
Takehiko Araki, Hideki Katsura, Motoji Sawabe, Kozui Kida   +3 more
openalex   +2 more sources

Rates and Characteristics of Serious Adverse Events (SAEs) in 210 Patients with Idiopathic Pulmonary Fibrosis (IPF) Treated with Interferon-Gamma 1b (IFN-gamma 1b) in an Open-Label Study [PDF]

, 2004
David A. Zisman, Karen M. Starko, Williamson Z. Bradford   +2 more
openalex   +1 more source

Identification of genetic indicators linked to immunological infiltration in idiopathic pulmonary fibrosis. [PDF]

Medicine (Baltimore)
Huang Y, Ouyang Y, Luo W, Huang S.
europepmc   +1 more source

Efficacy of Interferon(IFN)-γ in Idiopathic Pulmonary Fibrosis [PDF]

, 2004
Joo Hun Park, Yeon‐Mok Oh, Tae Sun Shim, Chae‐Man Lim, Younsuck Koh, Sang‐Do Lee, Woo Sung Kim, Won Dong Kim, Dong Soon Kim   +8 more
openalex   +1 more source

BPIFB1 is a prognostic biomarker and mediated collagen synthesis in idiopathic pulmonary fibrosis. [PDF]

Medicine (Baltimore)
Yang J, Ruan X, He J.
europepmc   +1 more source

Epidemiology of idiopathic pulmonary fibrosis in central and Western Pennsylvania. [PDF]

Respir Res
Linkov F, Chang YF, Ramanan H, Morgan RS, McTigue KM, Dimmock AEF, Bascom R, Kass DJ.   +7 more
europepmc   +1 more source